Biological health signals
Multi-layered epigenetic readouts designed to reflect underlying biological state, not just observable symptoms.
Vetra Bio combines epigenetic biology, longitudinal data and machine learning to reveal how animal health changes over time, supporting earlier and better-informed decisions.
Conventional veterinary care typically detects chronic conditions once meaningful biological change has occurred. Earlier, more continuous insight could help shift care from reactive to proactive.
Our platform is under development to translate molecular signals into interpretable, longitudinal insight about biological state.
Our platform is under development to translate epigenetic signals into interpretable, decision-ready insight.
Multi-layered epigenetic readouts designed to reflect underlying biological state, not just observable symptoms.
Modelling that aims to capture how distinct tissue systems shift over time, rather than a single global score.
Repeat measurements over months and years support insight into direction and pace of biological change.
Interpretable outputs intended to complement veterinary judgement and inform proactive care planning.
Curated longitudinal, cross-species datasets designed for biological signal discovery.
Epigenetic measurements selected for informativeness across tissues.
Machine learning approaches designed to capture direction, pace and context of change.
Outputs shaped for veterinary understanding and decision-support workflows.
A staged pipeline connecting biology, data and interpretation.
Minimally invasive sampling suitable for routine veterinary workflows.
Molecular signals measured across informative regions of the genome.
Machine learning models trained on longitudinal, multi-species datasets.
Interpretable outputs that describe biological direction over time.
Initial focus areas across species and contexts, developed with domain partners.
Supporting performance, welfare and long-term monitoring across the working life of the horse.
Enabling earlier biological insight for dogs and cats to inform proactive veterinary care.
Providing cross-species epigenetic tooling to accelerate translational animal health studies.
Exploring how biological trajectories could inform risk understanding at cohort scale.
Our scientific work focuses on how epigenetic signals reflect changing biological state, and how those signals can be responsibly translated into decision support.
Epigenetic patterns shift as tissues respond to internal and environmental signals. These patterns can encode information about biological state that is not visible through conventional testing.
Conserved methylation biology across mammals enables approaches that generalise across species while respecting species-specific context.
We are interested in signals that reflect the capacity of biological systems to maintain function under stress, not only markers of disease that has already emerged.
We follow a staged validation strategy spanning discovery, analytical validation, retrospective analysis, prospective piloting and utility assessment.
We communicate our work with care, avoid over-interpretation, and design our tools to support rather than replace qualified veterinary judgement.
We follow a structured validation approach. Progress is described honestly; no clinical or regulatory claims are implied.
Signal identification across curated multi-species epigenetic datasets.
Assessment of measurement reproducibility, precision and robustness.
Evaluation against historical longitudinal cohorts.
Structured deployment with veterinary and research partners.
Study of decision-support value in real-world veterinary contexts.
An honest snapshot of where we are today.
Complementary expertise across epigenetics, multi-omics, machine learning, translational science and commercialisation.
We welcome conversations with investors, veterinary partners, researchers and prospective hires.